{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T16:49:49Z","timestamp":1790700589111,"version":"4.1.0"},"reference-count":36,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2015,10,1]],"date-time":"2015-10-01T00:00:00Z","timestamp":1443657600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100008363","name":"Danish Cancer Society","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100008363","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["thegreenjournal.com","clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Radiotherapy and Oncology"],"published-print":{"date-parts":[[2015,10]]},"DOI":"10.1016\/j.radonc.2015.07.004","type":"journal-article","created":{"date-parts":[[2015,8,6]],"date-time":"2015-08-06T21:48:16Z","timestamp":1438897696000},"page":"91-98","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":58,"title":["The DAHANCA 6 randomized trial: Effect of 6 vs 5 weekly fractions of radiotherapy in patients with glottic squamous cell carcinoma"],"prefix":"10.1016","volume":"117","author":[{"given":"Nina M.","family":"Lyhne","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanne","family":"Primdahl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claus A.","family":"Kristensen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elo","family":"Andersen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00f8rgen","family":"Johansen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisbeth J.","family":"Andersen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan","family":"Evensen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanna R.","family":"Mortensen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jens","family":"Overgaard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.radonc.2015.07.004_b0005","doi-asserted-by":"crossref","first-page":"131","DOI":"10.3109\/02841868809090333","article-title":"The hazard of accelerated tumor clonogen repopulation during radiotherapy","volume":"27","author":"Withers","year":"1988","journal-title":"Acta Oncol"},{"key":"10.1016\/j.radonc.2015.07.004_b0010","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/S0167-8140(97)01904-X","article-title":"Importance of overall treatment time for the outcome of radiotherapy of advanced head and neck carcinoma: dependency on tumor differentiation","volume":"43","author":"Hansen","year":"1997","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2015.07.004_b0015","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1016\/S0140-6736(03)14361-9","article-title":"Five compared with six fractions per week of conventional radiotherapy of squamous-cell carcinoma of head and neck: DAHANCA 6 and 7 randomised controlled trial","volume":"362","author":"Overgaard","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.radonc.2015.07.004_b0020","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.radonc.2011.02.010","article-title":"The influence of HPV-associated p16-expression on accelerated fractionated radiotherapy in head and neck cancer: evaluation of the randomised DAHANCA 6&7 trial","volume":"100","author":"Lassen","year":"2011","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2015.07.004_b0025","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.radonc.2004.12.018","article-title":"(DAHANCA) DH and NC study group. The influence of epidermal growth factor receptor and tumor differentiation on the response to accelerated radiotherapy of squamous cell carcinomas of the head and neck in the randomized DAHANCA 6 and 7 study","volume":"74","author":"Eriksen","year":"2005","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2015.07.004_b0030","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.radonc.2012.01.002","article-title":"Prevalence and peak incidence of acute and late normal tissue morbidity in the DAHANCA 6&7 randomised trial with accelerated radiotherapy for head and neck cancer","volume":"103","author":"Mortensen","year":"2012","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2015.07.004_b0035","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.3109\/0284186X.2013.824609","article-title":"Factors associated with acute and late dysphagia in the DAHANCA 6 & 7 randomized trial with accelerated radiotherapy for head and neck cancer","volume":"52","author":"Mortensen","year":"2013","journal-title":"Acta Oncol"},{"key":"10.1016\/j.radonc.2015.07.004_b0040","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.radonc.2010.12.010","article-title":"Two-year results from a Swedish study on conventional versus accelerated radiotherapy in head and neck squamous cell carcinoma\u2013the ARTSCAN study","volume":"100","author":"Zackrisson","year":"2011","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2015.07.004_b0045","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/S0167-8140(97)01944-0","article-title":"A randomised trial of accelerated versus conventional radiotherapy in head and neck cancer","volume":"43","author":"Jackson","year":"1997","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2015.07.004_b0050","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/S0360-3016(02)03792-6","article-title":"Locoregionally advanced carcinoma of the oropharynx: conventional radiotherapy vs. accelerated hyperfractionated radiotherapy vs. concomitant radiotherapy and chemotherapy\u2013a multicenter randomized trial","volume":"55","author":"Olmi","year":"2003","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2015.07.004_b0055","doi-asserted-by":"crossref","unstructured":"Zackrisson B, Kjell\u00e9n Elisabeth, S\u00f6derstr\u00f6m K, Brun E, Nyman J NP. Five-year results from a Swedish study on conventional versus accelerated radiotherapy in head and neck squamous cell carcinoma \u2013 the ARTSCAN trial. Radiother Oncol 2015; Accepted for publication.","DOI":"10.1016\/j.radonc.2015.09.024"},{"key":"10.1016\/j.radonc.2015.07.004_b0060","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0167-8140(01)00494-7","article-title":"A multicentre randomized\/controlled trial of a conventional versus modestly accelerated radiotherapy in the laryngeal cancer: influence of a 1 week shortening overall time","volume":"62","author":"Hliniak","year":"2002","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2015.07.004_b0065","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/S0167-8140(97)00079-0","article-title":"Accelerated fractionation (AF) compared to conventional fractionation (CF) improves loco-regional control in the radiotherapy of advanced head and neck cancers: results of the EORTC 22851 randomized trial","volume":"44","author":"Horiot","year":"1997","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2015.07.004_b0070","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.ijrobp.2013.12.027","article-title":"Final results of local-regional control and late toxicity of RTOG 9003: a randomized trial of altered fractionation radiation for locally advanced head and neck cancer","volume":"89","author":"Beitler","year":"2014","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2015.07.004_b0075","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/S0167-8140(00)00139-0","article-title":"Randomized clinical trial on 7-day-continuous accelerated irradiation (CAIR) of head and neck cancer \u2013 report on 3-year tumour control and normal tissue toxicity","volume":"55","author":"Skladowski","year":"2000","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2015.07.004_b0080","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1016\/S0140-6736(06)69121-6","article-title":"Hyperfractionated or accelerated radiotherapy in head and neck cancer: a meta-analysis","volume":"368","author":"Bourhis","year":"2006","journal-title":"Lancet"},{"key":"10.1016\/j.radonc.2015.07.004_b0085","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1111\/coa.12139","article-title":"Radiotherapy for T1\u20132N0 glottic cancer: a multivariate analysis of predictive factors for the long-term outcome in 1050 patients and a prospective assessment of quality of life and voice handicap index in a subset of 233 patients","volume":"38","author":"Al-Mamgani","year":"2013","journal-title":"Clin Otolaryngol"},{"key":"10.1016\/j.radonc.2015.07.004_b0090","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.ijrobp.2005.06.014","article-title":"Radiotherapy for early glottic carcinoma (T1N0M0): results of prospective randomized study of radiation fraction size and overall treatment time","volume":"64","author":"Yamazaki","year":"2006","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2015.07.004_b0095","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.radonc.2013.09.016","article-title":"A prospective randomized trial comparing hypofractionation with conventional fractionation radiotherapy for T1\u20132 glottic squamous cell carcinomas: results of a Korean Radiation Oncology Group (KROG-0201) study","volume":"110","author":"Moon","year":"2014","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2015.07.004_b0100","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1016\/j.ijrobp.2014.04.041","article-title":"Randomized trial of hyperfractionation versus conventional fractionation in T2 squamous cell carcinoma of the vocal cord (RTOG 9512)","volume":"89","author":"Trotti","year":"2014","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2015.07.004_b0105","first-page":"313","article-title":"Importance of overall treatment time for the response to radiotherapy in patients with squamous cell carcinoma of the head and neck","volume":"25","author":"Overgaard","year":"2000","journal-title":"Rays"},{"key":"10.1016\/j.radonc.2015.07.004_b0110","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/S0167-8140(97)00094-7","article-title":"A randomised multicentre trial of CHART versus conventional radiotherapy in head and neck cancer","volume":"44","author":"Dische","year":"1997","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2015.07.004_b0115","doi-asserted-by":"crossref","first-page":"147","DOI":"10.3109\/02841868809090334","article-title":"Comparison of conventional and split-course radiotherapy as primary treatment in carcinoma of the larynx","volume":"27","author":"Overgaard","year":"1988","journal-title":"Acta Oncol"},{"key":"10.1016\/j.radonc.2015.07.004_b0120","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.radonc.2011.05.036","article-title":"Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): a comprehensive analysis by tumour site","volume":"100","author":"Blanchard","year":"2011","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2015.07.004_b0125","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.3109\/0284186X.2014.992547","article-title":"Locally advanced Head and Neck cancer treated with accelerated radiotherapy, the hypoxic modifier nimorazole and weekly cisplatin. Results from the DAHANCA 18 phase II study","volume":"54","author":"Bentzen","year":"2015","journal-title":"Acta Oncol"},{"key":"10.1016\/j.radonc.2015.07.004_b0130","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/S0167-8140(97)00220-X","article-title":"A randomized double-blind phase III study of nimorazole as a hypoxic radiosensitizer of primary radiotherapy in supraglottic larynx and pharynx carcinoma. Results of the Danish Head and Neck Cancer Study (DAHANCA) Protocol 5\u201385","volume":"46","author":"Overgaard","year":"1998","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2015.07.004_b0135","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1016\/0360-3016(89)90917-6","article-title":"Misonidazole combined with split-course radiotherapy in the treatment of invasive carcinoma of larynx and pharynx: report from the DAHANCA 2 study","volume":"16","author":"Overgaard","year":"1989","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2015.07.004_b0140","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1056\/NEJM199106133242402","article-title":"Induction chemotherapy plus radiation compared with surgery plus radiation in patients with advanced laryngeal cancer","volume":"324","year":"1991","journal-title":"N Engl J Med"},{"key":"10.1016\/j.radonc.2015.07.004_b0145","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/S0895-4356(00)00295-X","article-title":"Glottic cancer in Ontario, Canada and the SEER areas of the United States. Do different management philosophies produce different outcome profiles?","volume":"54","author":"Groome","year":"2001","journal-title":"J Clin Epidemiol"},{"key":"10.1016\/j.radonc.2015.07.004_b0150","doi-asserted-by":"crossref","first-page":"285","DOI":"10.3109\/0284186X.2012.742964","article-title":"The impact of comorbidity on outcome in 12 623 Danish head and neck cancer patients: a population based study from the DAHANCA database","volume":"52","author":"Boje","year":"2013","journal-title":"Acta Oncol"},{"key":"10.1016\/j.radonc.2015.07.004_b0155","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1080\/028418698430467","article-title":"Lymph node metastases from laryngeal and pharyngeal carcinomas\u2013calculation of burden of metastasis and its impact on prognosis","volume":"37","author":"Jakobsen","year":"1998","journal-title":"Acta Oncol"},{"key":"10.1016\/j.radonc.2015.07.004_b0160","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/S0167-8140(02)00118-4","article-title":"Glottic carcinoma\u2013patterns of failure and salvage treatment after curative radiotherapy in 861 consecutive patients","volume":"63","author":"Johansen","year":"2002","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2015.07.004_b0165","doi-asserted-by":"crossref","first-page":"419","DOI":"10.3109\/0284186X.2011.653438","article-title":"Importance of hemoglobin concentration and its modification for the outcome of head and neck cancer patients treated with radiotherapy","volume":"51","author":"Hoff","year":"2012","journal-title":"Acta Oncol"},{"key":"10.1016\/j.radonc.2015.07.004_b0170","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1016\/S1470-2045(10)70072-3","article-title":"Five versus six fractions of radiotherapy per week for squamous-cell carcinoma of the head and neck (IAEA-ACC study): a randomised, multicentre trial","volume":"11","author":"Overgaard","year":"2010","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.radonc.2015.07.004_b0175","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.ijrobp.2014.07.022","article-title":"RTOG 9003: Legacies of a Landmark Trial","volume":"90","author":"Trotti","year":"2014","journal-title":"Int J Radiat Oncol"},{"key":"10.1016\/j.radonc.2015.07.004_b0180","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1016\/j.ijrobp.2015.02.051","article-title":"Final Report of Radiation Therapy Oncology Group Protocol 9003: provocative, but limited conclusions from exploratory analyses","volume":"92","author":"Rosenthal","year":"2015","journal-title":"Int J Radiat Oncol"}],"container-title":["Radiotherapy and Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167814015003503?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167814015003503?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,20]],"date-time":"2018-09-20T11:26:21Z","timestamp":1537442781000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0167814015003503"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,10]]},"references-count":36,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,10]]}},"alternative-id":["S0167814015003503"],"URL":"https:\/\/doi.org\/10.1016\/j.radonc.2015.07.004","relation":{},"ISSN":["0167-8140"],"issn-type":[{"value":"0167-8140","type":"print"}],"subject":[],"published":{"date-parts":[[2015,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The DAHANCA 6 randomized trial: Effect of 6 vs 5 weekly fractions of radiotherapy in patients with glottic squamous cell carcinoma","name":"articletitle","label":"Article Title"},{"value":"Radiotherapy and Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.radonc.2015.07.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Ireland Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}